References
- Wilkins K, Mao Y. Trends in rates of admission to hospital and death from asthma among children and young adults in Canada during the 1980's. Can Med Assoc J 1993; 148(2)185–190
- Beasley R, Crane N., Pearce J, Windom H, Burgess C. Asthma mortality and inhaled beta agonist therapy. Aust NZ J Med 1991; 21: 753–763
- Wilson J D, Sutherland D C, Thomas A C. Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma?. Lancet 1981; 1: 1235–1237
- Ireland A W, Lawson J S. The changing face of death: Recent trends in Australian mortality. Med J Aust 1980; 24: 587–590
- MaoManfreda J. Y, Litven W. Morbidity and mortality from chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: S19–S26
- Mao Y, Semenciw R, Morrison H, MacWilliams H, Davies J, Wigle D. Increased rates of illness and death from asthma in Canada. Can Med Assoc J 1987; 137: 620–624
- Zalesky C., Collins-Williams C, Battu K, Chambers M T. Death from asthma. Can Med Assoc J 1981; 125: 341–345
- Bates V D, Baker-Anderson M. Asthma mortality and morbidity in Canada. J Allerg Clin Immunol 1987; 80(3, Suppl 2)395–397
- Enarson D A, Newman S C, Fan R-L, MacArthur C. Chronic airways obstruction leading to chronic hypoxemic respiratory failure: An estimate of the size and trend of the problem in Canada. Bull Int Union Tuberc Lung Dis 1991; 66: 113–123
- Walker C L, Greenberger P A, Patterson R. Potentially fatal asthma. Ann Allergy 1990; 64: 487–493
- Robin E D. Death from bronchial asthma. Chest 1988; 93: 614–618
- Ruffin R E, Latimer K M, Schembri D A. Longitudinal study of near fatal asthma. Chest 1991; 99: 77–83
- Crane J, Pearce N, Woodman C., Burgess K, Robson B, Beasley R. Marker of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 1992; 21: 737–744
- Gergen P J, Weiss K B. Changing patterns of asthma hospitalization among children: 1979–1987. JAMA 1990; 264: 1688–1692
- Weiss K B, Wagener D K. Changing patterns of asthma mortality: Identifying target populations at high risk. JAMA 1990; 264: 1683–1687
- Weiss K B, Wagener D K. Asthma surveillance in the United States: A review of current trends and knowledge gaps. Chest 1990; 98(Suppl)179S–184S
- Spitzer W O, ET A L. The use of β-agonist and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–506
- Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R. Prescribed fenoterol and death from asthma in New Zealand. Lancet 1989; 1: 917–922
- Barger L W, Vollmer W M, Felt R W, Buist A S. Further investigation into the recent increase in asthma death rates. A review of 41 asthma deaths in Oregon in 1982. Am Allergy 1988; 60: 31–39
- Jhangri G, Lauris G, Kelly S, Guidotti T L. Mortality by Cause: Alberta, 1927 to 1987. University of Alberta Occupational Health Program, Edmonton October, 1990, Alberta Studies in Occupational Health, No. 4
- Ebi-Kryston K L. Predicting 15-year chronic bronchitis mortality in the Whitehall Study. J Epidemiol Commun Health 1989; 43: 168–172
- Warren P M, Flenley D C, Miller J S, Avery A. Respiratory failure revisited: Acute exacerbations of chronic bronchitis between 1961–68 and 1970–76. Lancet 1980; 1: 467–470
- Chronic obstructive pulmonary disease mortality—United States, 1986. MMWR 1989; 38: 549–552
- Bailey W C, Richards J M, Jr, Brooks C M, Soong S-J, Brannen A L. Features of asthma in older adults. J Asthma 1992; 29: 21–28
- Sweet L, Fan J SK, O'Neill J. A validation study of asthma, Prince Edward Island, 1984–1988. I. Cause of death. Chron Dis Canada 1992; 13(1)1–4
- Stellman J L, Spicer J E, Clayton R M. Morbidity from chronic asthma. Thorax 1982; 37: 218–221
- National Asthma Education Program: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute, Bethesda, MD 1991, Publication No. 91–3042,August
- Tierstein A S. The differential diagnosis of asthma. Mt Sinai J Med 1991; 58: 466–471
- Pride N B. Some problems with current labels. Eur Respir J 1990; 3: 1078–1097
- Vermeire P. An international questionnaire survey and its implications. Eur Respir J 1990; 3: 1081–1082
- Demedts M. The assessment of reversibility: What physiological tests?. Eur Respir J 1990; 3: 1084–1087
- Boulet L-P, Deschesnes F, Turcotte H, Bibnac F. Near-fatal asthma. Clinical and physiologic features, perception of bronchoconstriction, and physiologic profile. J Allergy Clin Immunol 1991; 88: 838–846
- Sweet L, Fan J SK, O'Neill J. A validation study of asthma, Prince Edward Island, 1984–1988. II. Hospitalizations. Chron Dis Canada 1992; 13(2)19–23